0001179110-16-030045.txt : 20160927 0001179110-16-030045.hdr.sgml : 20160927 20160927162437 ACCESSION NUMBER: 0001179110-16-030045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160927 FILED AS OF DATE: 20160927 DATE AS OF CHANGE: 20160927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Almstead Neil Gregory CENTRAL INDEX KEY: 0001578850 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 161904672 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 4 1 edgar.xml FORM 4 - X0306 4 2016-09-27 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001578850 Almstead Neil Gregory C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 EVP Research Pharma Ops & Tech Common Stock 2016-09-27 4 M 0 3414 10.85 A 3414 D Common Stock 2016-09-27 4 M 0 6586 10.85 A 10000 D Common Stock 1295 I By spouse Stock Option (Right to Buy) 10.85 2016-09-27 4 M 0 3414 10.85 D 2023-05-15 Common Stock 3414 66898 D Stock Option (Right to Buy) 10.85 2016-09-27 4 M 0 6586 10.85 D 2023-05-15 Common Stock 6586 3102 D Stock Option (Right to Buy) 27.05 2024-01-27 Common Stock 40000 40000 D Stock Option (Right to Buy) 51.00 2025-01-01 Common Stock 69550 69550 D Stock Option (Right to Buy) 30.86 2026-01-03 Common Stock 55000 55000 D Stock Option (Right to Buy) 218.4 2022-01-10 Common Stock 166 166 D Stock Option (Right to Buy) 490.8 2021-04-27 Common Stock 216 216 D Stock Option (Right to Buy) 1149.6 2020-02-02 Common Stock 200 200 D Stock Option (Right to Buy) 451.2 2019-05-15 Common Stock 200 200 D Stock Option (Right to Buy) 735.6 2018-04-01 Common Stock 194 194 D Stock Option (Right to Buy) 735.6 2018-01-25 Common Stock 166 166 D Stock Option (Right to Buy) 626.4 2017-04-18 Common Stock 137 137 D Stock Option (Right to Buy) 10.85 2023-05-15 Common Stock 600 600 I By spouse Stock Option (Right to Buy) 27.05 2024-01-27 Common Stock 1300 1300 I By spouse Stock Option (Right to Buy) 51.00 2025-01-01 Common Stock 2060 2060 I By spouse Restricted Stock Unit Common Stock 750 750 I By spouse Stock Option (Right to Buy) 218.4 2022-01-10 Common Stock 7 7 I By spouse Stock Option (Right to Buy) 490.8 2021-04-27 Common Stock 7 7 I By spouse Stock Option (Right to Buy) 1149.6 2020-02-02 Common Stock 1 1 I By spouse Stock Option (Right to Buy) 508.8 2019-10-07 Common Stock 12 12 I By spouse This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014. This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015. This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017. This restricted stock unit (RSU) award was granted on January 4, 2016 and vests in equal installments over four years on each anniversary of the grant date. Upon vesting, each RSU will convert into one share of common stock of the Issuer. Currently exercisable. /s/ Colleen Diver Johnson, attorney-in-fact 2016-09-27